NCT05441930View on ClinicalTrials.gov

A Study of Levofloxacin Ocular Implant in Patients Undergoing Routine Bilateral Cataract Surgery

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 23, 2023

Primary Completion Date

December 15, 2023

Study Completion Date

March 14, 2024

Conditions
Cataract
Interventions
DRUG

Levofloxacin Ocular Implant

Levofloxacin Ocular Implant an implant that delivers a bolus dose of levofloxacin and a constant daily dose for a further 5-7 days.

DRUG

Control

Commercially available topical medications as per LEVO-CS102 Surgical Therapy Procedure.

Trial Locations (3)

3065

Melbourne Eye Specialists, Fitzroy

29456

Carolina Cataract and Laser Centre, Ladson

63131

Ophthalmology Associates, St Louis

Sponsors

Lead Sponsor

PolyActiva Pty Ltd
All Listed Sponsors
lead

PolyActiva Pty Ltd

INDUSTRY

NCT05441930 - A Study of Levofloxacin Ocular Implant in Patients Undergoing Routine Bilateral Cataract Surgery | Biotech Hunter | Biotech Hunter